Fourrts I Laboratories Private Limited — Naproxen Exporter Profile
Indian Pharmaceutical Exporter · #13 for Naproxen · $1.9M export value · DGFT Verified
Fourrts I Laboratories Private Limited is the #13 Indian exporter of Naproxen with $1.9M in export value and 47 verified shipments. Fourrts I Laboratories Private Limited holds a 1.5% market share in Naproxen exports across 2 countries.
Fourrts I Laboratories Private Limited — Naproxen Export Profile: Buyers & Destinations
Where Does Fourrts I Laboratories Private Limited Export Naproxen?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SPAIN | $2.2M | 85 | 84.7% |
| UNITED KINGDOM | $398.7K | 11 | 15.3% |
| MALTA | $12 | 2 | 0.0% |
Fourrts I Laboratories Private Limited exports Naproxen to 3 countries. The largest destination is SPAIN accounting for 84.7% of Fourrts I Laboratories Private Limited's Naproxen shipments, followed by UNITED KINGDOM (15.3%) and MALTA (0.0%). These destinations reflect Fourrts I Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Naproxen from Fourrts I Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ATNAHS PHARMA UK LIMITED | SPAIN | $2.0M | 79 |
| NOUMED LIFE SCIENCES LIMITED | UNITED KINGDOM | $398.7K | 11 |
| ALLOGA BOROX | SPAIN | $150.0K | 6 |
| MISOM LABS LIMITED | MALTA | $12 | 2 |
Fourrts I Laboratories Private Limited supplies Naproxen to 4 buyers globally. The largest buyer is ATNAHS PHARMA UK LIMITED (SPAIN), followed by NOUMED LIFE SCIENCES LIMITED (UNITED KINGDOM) and ALLOGA BOROX (SPAIN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Naproxen Export Value and How Much Does Fourrts I Laboratories Private Limited Contribute?
India exported $77.8M worth of Naproxen through 3,414 shipments from 192 suppliers to 76 countries, serving 366 buyers globally. Fourrts I Laboratories Private Limited contributes $1.9M to this total, accounting for 1.5% of India's Naproxen exports. Fourrts I Laboratories Private Limited ships Naproxen to 3 countries through 4 buyers.
What Is the Average Shipment Value for Fourrts I Laboratories Private Limited's Naproxen Exports?
Fourrts I Laboratories Private Limited's average Naproxen shipment value is $41.3K per consignment, based on 47 shipments totaling $1.9M. The largest destination is SPAIN (84.7% of Fourrts I Laboratories Private Limited's Naproxen exports).
How Does Fourrts I Laboratories Private Limited Compare to Other Indian Naproxen Exporters?
Fourrts I Laboratories Private Limited ranks #13 among 192 Indian Naproxen exporters with a 1.5% market share. The top 3 exporters are GLENMARK PHARMACEUTICALS LIMITED ($14.1M), UNICHEM LABORATORIES LIMITED ($13.8M), GRANULES INDIA LIMITED ($8.5M). Fourrts I Laboratories Private Limited processed 47 shipments to 2 destination countries.
What Naproxen Formulations Does Fourrts I Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ANTALGIN 550MG NAPROXEN SODIUM TABLETS550MG PACK SIZE 4X10S | $1.8M | 42 |
| ANTALGIN 550MG NAPROXEN SODIUM TABLETS | $400.0K | 8 |
| NAPROXEN 500MG TABLETS 78869X2 X14PKS | $100.0K | 2 |
| NAPROXEN 500MG TABLETS 52359X2 X14PKS | $80.0K | 2 |
| NAPROXEN 500MG TABLETS 79309X 2 X14S | $50.0K | 1 |
| NAPROXEN 500MG TABLETS 131699X 2 X14S | $50.0K | 1 |
| NAPROXEN 500MG TABLETS 52209 X2 X14S | $38.8K | 1 |
| NAPROXEN 500MG TABLETS 26349X2 X14 PKS | $20.1K | 1 |
| NAPROXEN 500MG TABLETS 26199X2 X14PKS | $20.0K | 1 |
| NAPROXEN 500MG TABLETS 26119X2 X14 PKS | $20.0K | 1 |
Fourrts I Laboratories Private Limited exports 17 distinct Naproxen formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ANTALGIN 550MG NAPROXEN SODIUM TABLETS550MG PACK SIZE 4X10S with 42 shipments worth $1.8M.
Regulatory Requirements: Exporting Naproxen to Key Markets
What Fourrts I Laboratories Private Limited must comply with to export Naproxen to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Fourrts I Laboratories Private Limited Compare to Nearest Naproxen Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | APOTEX RESEARCH PRIVATE LIMITED | $3.5M | 86 | 1 | $40.9K |
| 1 | MYLAN LABORATORIES LIMITED | $2.8M | 55 | 3 | $50.0K |
| 13 | FOURRTS I LABORATORIES PRIVATE LIMITED ★ | $1.9M | 47 | 2 | $41.3K |
| 14 | MEDREICH LIMITED | $1.9M | 101 | 4 | $18.8K |
| 15 | S KANT HEALTHCARE LIMITED | $1.6M | 36 | 1 | $45.7K |
Fourrts I Laboratories Private Limited ranks #13 among 192 Indian Naproxen exporters. Average shipment value of $41.3K compared to the market average of $405.2K. The closest competitors by value are APOTEX RESEARCH PRIVATE LIMITED and MYLAN LABORATORIES LIMITED.
Which Indian Ports Ship Naproxen Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 429 | 12.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 245 | 7.2% |
| SAHAR AIR | 236 | 6.9% |
| DELHI AIR CARGO ACC (INDEL4) | 211 | 6.2% |
| JNPT/ NHAVA SHEVA SEA | 156 | 4.6% |
| HYDERABAD ICD | 145 | 4.2% |
| VIZAG SEA | 140 | 4.1% |
| BANGALORE AIR | 128 | 3.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Naproxen — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Naproxen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Fourrts I Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 98 individual customs records matching Fourrts I Laboratories Private Limited exporting Naproxen, covering 17 formulations to 3 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 76+ countries, 366+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Naproxen Export Data from Fourrts I Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Fourrts I Laboratories Private Limited's Naproxen exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Fourrts I Laboratories Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Naproxen Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Fourrts I Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Naproxen. For current shipment-level data, contact TransData Nexus.